Close for now Do you hold SG, US, HK or MY stocks? How are you tracking them now?
View our Demo portfolio to learn how StocksCafe will do it for you intelligently!
Sign up for free now!

SGX:BFK - Pharmesis Intl (SGD 0.23) 2 Followers PHARMESIS INTERNATIONAL LTD.
Sector: Health Technology, Industry: Pharmaceuticals: Generic

Recent Earning Release - 26 Feb 2018

Add to WatchList

Set Alert

See related symbol P31


SGD 0.23    +0.0 (+0%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

21 Feb 2019


Overview

21 Feb 2019

52 Wk Range: 0.136 - 0.4

Day's Range: 0.23 - 0.23

Last Volume: 0

Last Close: SGD 0.23

Current Yield: 0%

Future Yield: [Friends Only]

Dividend Strength: [Friends Only]

21 Feb 2019

Metric BFK S.Median
Beta 0.07 0.27
VaR 70.19 37.69
E.Shortfall 111.31 54.32
Liquidity NA 24.17K

Fundamental

20 Feb 2019

PE: NA

Market Cap: 5.3M

Price Over Book: 0.303

Price Over Sales: 0.39

Return On Assets: -2%

Return On Equity: -2.7%

NAV Over Price: [Friends Only]

Screener

[Members Only]

Sign up for free to access most features of StocksCafe

Scorer

[Members Only]

Sign up for free to access most features of StocksCafe

Description

Pharmesis International Ltd. Is an investment holding company, which engages in the research, development, production, sale, and marketing of medicine and medicine formulated products for the treatment of illnesses relating to the liver and gall bladder. It operates through the following segments: Western Drugs, Traditional Chinese Medicine (TCM) Formulated Drugs, and Distribution. The Western Drugs segment involves in the chemically formulated drugs and is marketed under the Kinna brand. The TCM segment offers traditional Chinese medicine and is marketed under the Longlife brand. The Distribution segment consists of agency products and internally manufactured products which are marketed through the distribution arm. The company was founded on September 29, 2003 and is headquartered in Chengdu, China.

General

CEO: Xue Dan Wu

Founded Year: 2003

Headquarters: Chengdu

Shares Outstanding: 23M

Security Type: Stock

Sector: Health Technology

Industry: Pharmaceuticals: Generic

Useful Links
Homepage

Price Simulation

My Notes

You currently do not have notes about this stock.




Dividends Tax Rate
Tax Rate (%)

Min Commission (SGD)


Past Transactions Add Transactions

You do not have past transactions for this stock.


Shared Portfolios Stats
All Shared Portfolios
0% holds BFK (0/190)
0% recent buy involves BFK (0/150)
0% recent sell involves BFK (0/54)

*recent means in the last 14 days.


Similar Stocks HAW PAR CORP LTD

IX BIOPHARMA LTD.

UG HEALTHCARE CORPORATION LTD

STAR PHARMACEUTICAL LIMITED

SUNTAR ECO-CITY LIMITED